Form 4: Scotts Miracle-Gro Director David C. Evans Reports Acquisition of Dividend Equivalent Rights
SEC Form 4 Filing
Director David C. Evans reports acquiring 102 dividend equivalent rights related to existing DSU or RSU grants.
Summary
- On March 7, 2025, David C. Evans, a director of Scotts Miracle-Gro Co., acquired 102 dividend equivalent rights.
- These rights are associated with previously granted Deferred Stock Units (DSUs) or Restricted Stock Units (RSUs).
- The dividend equivalent rights become exercisable proportionally with the DSUs or RSUs to which they relate.
- Each dividend equivalent right represents the economic equivalent of one common share of Scotts Miracle-Gro.
- Following the transaction, Evans directly owns 461 dividend equivalent rights.
- The price of the dividend equivalent rights is $62.18.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of a routine transaction. It doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. This filing indicates a director's acquisition of dividend equivalent rights, which are common in executive compensation packages.
Stakeholder Impact
- The acquisition of dividend equivalent rights by a director could be perceived positively by shareholders as it aligns the director's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 03/07/2025 | Date of transaction: Acquisition of dividend equivalent rights |
| 03/11/2025 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.